COVID-19 大流行对院外心脏骤停(EMS 目击)发生率与生存结局的影响
该研究采用中断时间序列分析,纳入 2012 年 1 月 1 日至 2021 年 12 月 31 日期间澳大利亚维多利亚州成人、内科病因的 EMS 目击院外心脏骤停患者 5034 例,其中 comparator 期 3976 例(79.0%),COVID-19 期(2020 年 3 月 1 日至 2021 年 12 月 31 日)1058 例(21.0%)。COVID-19 期患者 EMS 响应时间更长、公共场所骤停更少,且更可能接受机械 CPR 和喉罩气道(均 p<0.05)。两期 EMS 目击 OHCA 发生率无显著差异(IRR 1.06,95%CI 0.97-1.17,p=0.19),风险校正后出院生存 odds 亦无差异(aOR 1.02,95%CI 0.74-1.42,p=0.90)。作者认为,与非 EMS 目击 OHCA 人群的报告不同,大流行期间的变化未影响 EMS 目击 OHCA 的发生率或生存结局。
要点
- COVID-19 期与 comparator 期 EMS 目击 OHCA 发生率无显著差异:IRR 1.06(95%CI 0.97-1.17,p=0.19)。
- COVID-19 期与 comparator 期风险校正后出院生存 odds 无差异:aOR 1.02(95%CI 0.74-1.42,p=0.90)。
- COVID-19 期患者 EMS 响应时间更长、公共场所骤停更少,更可能接受机械 CPR 和喉罩气道(均 p<0.05)。
- 作者认为,为减少气溶胶生成操作而改变的临床实践可能未影响此类患者的结局。
适用人群与场景
- 澳大利亚维多利亚州成人 EMS 目击的院外心脏骤停患者,病因限定为内科病因。
- COVID-19 期:2020 年 3 月 1 日至 2021 年 12 月 31 日治疗的患者。
- comparator 期:2012 年 1 月 1 日至 2020 年 2 月 28 日治疗的患者。
研究设计与关键结果
- 研究类型为中断时间序列分析,纳入 5034 例成人内科病因 EMS 目击 OHCA 患者,comparator 期 3976 例(79.0%),COVID-19 期 1058 例(21.0%)。
- COVID-19 期患者 EMS 响应时间更长、公共场所骤停更少,且更可能接受机械 CPR 和喉罩气道,与历史期相比均有统计学差异(均 p<0.05)。
- EMS 目击 OHCA 发生率在 comparator 期与 COVID-19 期无显著差异:发生率比 1.06(95%CI 0.97-1.17,p=0.19)。
- 风险校正后出院生存 odds 在 COVID-19 期与 comparator 期无差异:校正 OR 1.02(95%CI 0.74-1.42,p=0.90)。
证据类型、等级与局限
- 证据类型:中断时间序列分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与非 EMS 目击 OHCA 人群的报告不同,大流行期间的变化未影响 EMS 目击 OHCA 的发生率或生存结局。
- 作者认为,为限制气溶胶生成操作而改变的临床实践可能未影响这些患者的结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: We sought to examine the impact of the COVID-19 pandemic on the incidence and survival outcomes of emergency medical service (EMS)-witnessed out-of-hospital cardiac arrest (OHCA) in Victoria, Australia.
METHODS: We performed an interrupted time-series analysis of adult EMS-witnessed OHCA patients of medical aetiology. Patients treated during the COVID-19 period (1st March 2020 to 31st December 2021) were compared to a historical comparator period (1st January 2012 and 28th February 2020). Multivariable poisson and logistic regression models were used to examine changes in incidence and survival outcomes during the COVID-19 pandemic, respectively.
RESULTS: We included 5,034 patients, 3,976 (79.0%) in the comparator period and 1,058 (21.0%) in the COVID-19 period. Patients in the COVID-19 period had longer EMS response times, fewer public location arrests and were significantly more likely to receive mechanical CPR and laryngeal mask airways compared to the historical period (all p < 0.05). There were no significant differences in the incidence of EMS-witnessed OHCA between the comparator and COVID-19 periods (incidence rate ratio 1.06, 95% CI: 0.97-1.17, p = 0.19). Also, there was no difference in the risk-adjusted odds of survival to hospital discharge for EMS-witnessed OHCA occurring during COVID-19 period compared to the comparator period (adjusted odd ratio 1.02, 95% CI: 0.74-1.42; p = 0.90).
CONCLUSION: Unlike the reported findings in non-EMS-witnessed OHCA populations, changes during the COVID-19 pandemic did not influence incidence or survival outcomes in EMS-witnessed OHCA. This may suggest that changes in clinical practice that sought to limit the use of aerosol generating procedures did not influence outcomes in these patients.
参考来源
- Kennedy C, Alqudah Z, Stub D, et al. The effect of the COVID-19 pandemic on the incidence and survival outcomes of EMS-witnessed out-of-hospital cardiac arrest. Resuscitation. 2023. PMID: 36933880. doi:10.1016/j.resuscitation.2023.109770
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。